Chapuis, A. G., Lee, S. M., Thompson, J. A., Roberts, I. M., Margolin, K. A., Bhatia, S., . . . Yee, C. (2016). Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. The Journal of experimental medicine, 213(7), 1133. https://doi.org/10.1084/jem.20152021
Citace podle Chicago (17th ed.)Chapuis, Aude G., et al. "Combined IL-21-primed Polyclonal CTL Plus CTLA4 Blockade Controls Refractory Metastatic Melanoma in a Patient." The Journal of Experimental Medicine 213, no. 7 (2016): 1133. https://doi.org/10.1084/jem.20152021.
Citace podle MLA (9th ed.)Chapuis, Aude G., et al. "Combined IL-21-primed Polyclonal CTL Plus CTLA4 Blockade Controls Refractory Metastatic Melanoma in a Patient." The Journal of Experimental Medicine, vol. 213, no. 7, 2016, p. 1133, https://doi.org/10.1084/jem.20152021.